Bausch Health announced that DUOBRII, the company’s novel topical prescription drug for improving the signs and symptoms of plaque psoriasis in adult patients with moderate to severe disease, is now available to patients enrolled in Quebec’s public drug plan operated by the Regie de l’assurance maladie du Quebec.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on BHC: